|
Thu, 03/20/2025 - 18:09 |
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE Scaffold in Breast Implant Revision Surgery |
bd |
|
Thu, 03/20/2025 - 13:59 |
HHS, FDA Announce Chemical Contaminants Transparency Tool for Foods |
FDA |
|
Mon, 03/17/2025 - 11:16 |
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders |
OPKO |
|
Fri, 03/14/2025 - 15:09 |
FDA Educational Efforts Prevented Nearly 450,000 Youth from Starting E-Cigarette Use in One Year |
FDA |
|
Thu, 02/27/2025 - 04:39 |
US FDA grants Priority Review to Sobis supplemental Biologics Licence Application (sBLA) for Gamifant (emapalumab-lzsg) |
Swedish Orphan ... |
|
Fri, 02/21/2025 - 13:51 |
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease |
FDA |
|
Fri, 02/14/2025 - 20:25 |
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes |
FDA |
|
Wed, 02/05/2025 - 13:52 |
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices |
FDA |
|
Thu, 01/30/2025 - 19:52 |
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain |
FDA |
|
Thu, 01/30/2025 - 13:52 |
FDA Supports Swapping Single-Use Containers for Reusable, Refillable Ones |
Center for Biol... |
|
Sat, 01/18/2025 - 07:15 |
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S. |
Philip Morris |
|
Thu, 01/16/2025 - 21:06 |
Proposal to Lower Nicotine Levels Represents Historic Step Forward for Public Health |
Truth Initiative |
|
Thu, 01/16/2025 - 20:55 |
FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review |
FDA |
|
Wed, 01/15/2025 - 16:04 |
FDA Proposes Significant Step Toward Reducing Nicotine to Minimally or Nonaddictive Level in Cigarettes and Certain Other Combusted Tobacco Products |
FDA |
|
Tue, 01/14/2025 - 23:32 |
ACS CAN Applauds FDA Proposed Rule on Mandatory Front-of-Package Labeling Requirements |
ACS CAN |
|
Tue, 01/14/2025 - 14:55 |
FDA Proposes Requiring At-a-Glance Nutrition Information on the Front of Packaged Foods |
FDA |
|
Thu, 12/19/2024 - 00:39 |
FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease |
FDA |
|
Wed, 12/11/2024 - 22:31 |
Liquet Medical Inc. Receives FDA 510(k) Clearance for the Versus Catheter |
VABIO |
|
Tue, 10/29/2024 - 02:46 |
Proregulations' Comprehensive Regulatory Consulting Services Help Gain a Competitive Edge in the North American Market |
proregulations |
|
Tue, 08/27/2024 - 18:15 |
FDA Clears First Device to Enable Automated Insulin Dosing for Individuals with Type 2 Diabetes |
FDA |
|
Thu, 08/22/2024 - 15:53 |
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants |
FDA |
|
Thu, 08/22/2024 - 07:28 |
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study |
Exact Sciences |
|
Wed, 08/21/2024 - 22:56 |
ReAlta Granted FDA Orphan Drug Designation and Fast Track Designation for RLS-0071 for the Treatment of Steroid-Refractory Acute Graft-versus-Host Disease |
VABIO |
|
Sat, 08/17/2024 - 10:37 |
FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis |
FDA |
|
Thu, 08/08/2024 - 13:29 |
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose |
FDA |
